Procaine sales will expand through 2036, with procaine hydrochloride (hcl) at 52.4% and injectable solution at 46.8% in 2026. The market was valued at USD 28.3677 million in 2025, is projected to reach USD 51.6142 million by 2036 and is forecast to record a 5.5522% CAGR between 2026 and 2036.